Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints new financial head

François-Xavier Roger brings experience from Sanofi and in telecoms

Takeda Francois-Xavier RogerTakeda has appointed François-Xavier Roger as the company's new chief financial officer.

He will lead the integration and leadership of the finance functions across Takeda and will report to the company's president and CEO Yasuchika Hasegawa.

The move is a return to the pharma industry for Roger who was most recently chief financial officer at Millicom International Cellular, a digital and mobile telecoms company.

He gained experience in the life sciences while serving in several leadership roles at Sanofi, including time in Japan, Mexico, France and South Africa.

He has further experience in Asia as chief financial officer of Danone's operations in the Asia Pacific region based in Singapore.

“With a proven track record of global success in financial leadership positions at world-class companies in pharmaceutical and consumer product businesses, we are extremely pleased to add Roger to the senior leadership team at Takeda,” said Hasegawa.

Article by
Thomas Meek

9th September 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics